Cardiotrophin 1

From WikiMD's Medical Encyclopedia

(Redirected from Cardiotrophin-1)

Cardiotrophin 1 (CT-1) is a cytokine protein that is part of the interleukin 6 (IL-6) family. It is encoded in humans by the CTF1 gene. Cardiotrophin 1 is known for its role in cardiac development and function, as well as its involvement in various pathophysiological processes.

Function[edit]

Cardiotrophin 1 is a secreted protein that signals through the glycoprotein 130 (gp130)/leukemia inhibitory factor receptor (LIFR) complex. It is involved in a variety of biological processes, including cell proliferation, cell differentiation, and apoptosis. CT-1 is particularly important in the heart, where it promotes cardiomyocyte survival and growth, and helps to regulate the heart's response to damage or stress.

Clinical significance[edit]

Alterations in the expression or function of cardiotrophin 1 have been implicated in a number of diseases. For example, elevated levels of CT-1 have been found in patients with heart failure, suggesting that it may play a role in the pathogenesis of this condition. In addition, studies have shown that CT-1 can promote the survival of neurons, suggesting potential therapeutic applications in neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease.

Research[edit]

Research into cardiotrophin 1 is ongoing, with studies investigating its role in various diseases and potential therapeutic applications. For example, researchers are exploring the possibility of using CT-1 as a treatment for heart failure, based on its ability to promote cardiomyocyte survival and growth.

See also[edit]

References[edit]

Stub icon
   This article is a protein-related stub. You can help WikiMD by expanding it!
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Start your transformation today with W8MD weight loss centers.

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.